Introduction
============

In order to infect bacteria, bacteriophages use an attachment organelle known as the "tail," which recognizes the host cell and attaches the phage's capsid to it. The tail then acts as a molecular syringe to puncture the cell envelope and establish an inner channel that translocates genomic DNA and proteins from the capsid into the cell cytoplasm ([@B33]; [@B59]; [@B40]). Tailed bacteriophages (order *Caudovirales*) can be divided into three families: *Myoviridae* (long contractile tail), *Siphoviridae* (long non-contractile tail), and *Podoviridae* (short non-contractile tail) ([@B88]; [@B1]; [@B104]).

Interestingly, bacterial genomes often contain gene clusters encoding for structural elements that are evolutionary related to bacteriophage tail structures with regard to morphology, size, and the mechanism of action but without containing a phage capsid. This includes, e.g., the T6SS ([@B58]), needle-like particles such as the Afp from *Serratia entomophila* ([@B41]) or the PVC ([@B110]), as well as PTLBs such as the "pyocins" from *Pseudomonas aeruginosa* or the "monocins" from *Listeria monocytogenes* ([@B71]; [@B57]). PTLBs, also referred to as tailocins, are high-molecular weight protein particles that are widespread in bacteria and for a subset of which antibacterial activity against competing strains of the same species has been demonstrated ([@B32]; [@B82]). Two types of PTLBs have been identified: the R-type PTLBs, which are rigid and contractile and are related to *Myoviridae* tail structures ([@B45]; [@B42]), and the F-type PTLBs, which are flexible and non-contractile and are related to *Siphoviridae* tails ([@B95]; [@B34]; [@B55]). Both types are exemplified by the so far best-studied PTLBs, namely the R- and F-type pyocins from *P. aeruginosa* ([@B71]; [@B68]; [@B82]). A rather recently identified group of PTLBs are the R-type "diffocins" from *Clostridium difficile*, which constitute the only Gram-positive R-type PTLBs known to date ([@B28]; [@B82]).

R-type PTLBs share a common structure and mechanism with bacteriophage tails of the *Myoviridae* family and although they cannot independently replicate, it has been suggested that PTLBs should not be considered defective prophages but rather as specifically adapted to their function as antibacterial instruments ([@B71]; [@B58]; [@B32]). R-type PTLBs are produced and accumulate within the bacterium under SOS response conditions and are only released upon lysis of the cell ([@B63]; [@B108]; [@B57]). Whereas for members of other strains from the same species, contact with only a single particle can lead to cell death ([@B46]), cells harboring the respective PTLB genes themselves are provided with a resistance mechanism ([@B83]; [@B49]). Thus, sister cells of the same strain gain advantage from self-sacrifice of one member during which PTLBs are released ([@B57]; [@B82]).

All R-type PTLBs consist of an inner needle-like rigid tube surrounded by a contractile sheath. Both of these complexes are composed of disks that assemble from six sheath or tube subunits via an axial sixfold rotational symmetry and are stacked atop each other after right-handed rotation ([@B38]; [@B26]; [@B72]; [@B15]; [@B80]). With up to 200 copies of the individual subunits in one sheath or tube assembly ([@B94]), these proteins constitute the main body of the particle, which is capped by a complex baseplate structure with six attached receptor-binding proteins ([@B26]; [@B97]). These proteins are responsible for recognition and binding to specific receptors on the surface of the target cell and thus determine the very narrow specificity spectrum for a subset of strains within the species ([@B66]; [@B71]; [@B108]; [@B49]; [@B28]; [@B48]). Binding triggers extensive conformational changes in the baseplate, accompanied by contraction of the sheath, which, due to extensive interactions, drives the rigid inner tube into the cell envelope. The driving force of sheath contraction and subsequent movement of the tube resides in the high-energy metastable structure of the extended state of the sheath ([@B5]; [@B59]; [@B26]; [@B96]; [@B15]). As a consequence of the puncturing, ions can pass through the tube, resulting in fast dissipation of the membrane potential and death of the attacked cell (**Figure [1](#F1){ref-type="fig"}**) ([@B103]; [@B90]). Thus, the complex network between the contractile sheath and the rigid tube is essential for the killing potency of R-type PTLBs ([@B26]; [@B52]; [@B15]; [@B82]).

![The genome of *Clostridium difficile* strain CD630 contains a 25-gene cluster encoding the R-type "diffocin." Diffocins form after SOS induction and are released by cell lysis to bind closely related but unprotected *C. difficile* strains. Contraction of the diffocin sheath (orange) drives the tube (blue) through the wall of the attacked cell and leads to death by dissipation of the membrane potential.](fmicb-09-01750-g001){#F1}

Their impressive killing capacity makes R-type PTLBs promising candidates for an efficient treatment of bacterial infections and, given their narrow strain-specificity, it seems likely that they can be administered without the risk of transmissible resistance or adverse effects on the beneficial flora ([@B31]; [@B9]; [@B82]). Additionally, several studies demonstrated that R-type PTLBs can be specifically bioengineered to target also other species or strains ([@B108]; [@B83], [@B84]), and prove-of-concept studies have been conducted to treat the respective infections ([@B67]; [@B35]; [@B86]; [@B77]; [@B27]). Thus, R-type PTLBs could serve as novel therapeutics to treat infections particularly caused by antibiotic-resistant bacteria.

The anaerobic Gram-positive bacterium *C. difficile* is a human pathogen that can be found in the intestine of humans as well as animals ([@B36]; [@B56]; [@B29]; [@B8]). Symptoms of infections range from diarrhea to life-threatening pseudomembranous colitis ([@B76]; [@B14]) and *C. difficile*-associated morbidity and mortality in humans has increased in recent years ([@B60]). *C. difficile* and its spores are resistant to a range of antibiotics as well as to various environmental factors and can therefore form reservoirs in healthcare settings, which significantly enhances the risk for hospital-acquired infections ([@B12]; [@B112]; [@B105]; [@B98]; [@B89]). Additionally, a preceding treatment with broad-spectrum antibiotics constitutes a major risk factor for CDIs since the protective microbiome in the gut is disrupted, providing a less competitive habitat for relapsing *C. difficile* ([@B101]). Therefore, alternatives to conventional antibiotics are urgently needed to specifically target *C. difficile*, and the R-type diffocins, possibly after bioengineering, constitute promising candidates ([@B27]). Toward this, insights into their three-dimensional structures could provide valuable information about their activity, assembly, and specificity. In this respect, R-type pyocins from *P. aeruginosa* are currently the most thoroughly studied R-type PTLBs, whereas structural information for other particles such as the *C. difficile* R-type diffocins is largely absent. Additionally, in contrast to prophage-like elements and bacteriophage tails, no crystal structures of the free sheath and tube building blocks are available, which precludes insights into the pre-assembly states of these proteins. Here, we therefore aimed at determining the crystal structures of these components from *C. difficile* strain CD630 individually. By extensive comparison with homologous structures, we demonstrate that several conformational changes are required in order to form the R-type diffocin particle. We also provide a model of the assembled sheath and tube structures of the R-type diffocin contractile apparatus, which may serve as templates for future cryo electron microscopy (cryo-EM) studies.

Materials and Methods {#s1}
=====================

Cloning, Expression, and Purification
-------------------------------------

The genes encoding the R-type diffocin sheath protein CD1363 and tube protein CD1364 were PCR-amplified from genomic *C. difficile* CD630 DNA, kindly provided by Prof. Dr. Ralf Gerhard (Hannover Medical School, Hannover, Germany). Both genes were subcloned into a pOPINM expression vector (Addgene plasmid \# 26044; a kind gift from Ray Owens; [@B11]) via SLIC ([@B61]), using appropriate oligonucleotide primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"} to yield fusion proteins with N-terminal 6xHis-MBP-tags and HRV3C protease cleavage sites. Positive clones of both constructs were identified with colony PCR and the correct sequence was verified via sequencing. Optimal conditions for recombinant protein production were determined in small-scale test expression experiments and large-scale expression was performed with *Escherichia coli* BL21-CodonPlus-RIL cells (Agilent Technologies, Santa Clara, CA, United States) for 24 h in M9 minimal medium ([@B69]) at 20°C for seleno-[[L]{.smallcaps}]{.smallcaps}-methionine-(SeMet-)labeled sheath protein CD1363 or in auto-induction medium ([@B92]) at 25°C for native tube protein CD1364. Cell pellets were resuspended in 20 mM HEPES, 300 mM NaCl, 3 mM DTT, pH 7.5, homogenized and centrifuged. The supernatants were applied onto a 5 mL MBPTrap HP column on an ÄKTA system (GE Healthcare Life Sciences, Pittsburgh, PA, United States) and eluted with 10 mM maltose in the same buffer. Tags were cleaved off with HRV3C protease at 4°C and overnight incubation. To subsequently remove cleaved affinity tags and uncleaved protein, a nickel affinity chromatography step was performed via a 5 mL HisTrap^TM^ HP chelating column (GE Healthcare Life Sciences) and the flow-through containing the respective protein was concentrated using a Vivaspin 6 10 kDa cutoff concentrator (GE Healthcare Life Sciences). As a polishing step, the proteins were passed through a Superdex 75 16/60 or 26/60 prep grade column (GE Healthcare Life Sciences) and fractions containing the proteins of interest were concentrated and dialyzed against 20 mM HEPES, 300 mM NaCl, 3 mM DTT, pH 7.5. Protein purity was assessed by SDS-PAGE and protein concentrations were determined spectroscopically using calculated extinction coefficients based on the amino acid sequence via the PROTPARAM web server^[1](#fn01){ref-type="fn"}^ ([@B25]). The correct molecular masses of the purified proteins were confirmed at the Department Chemical Biology at the Helmholtz Center for Infection Research, using a maXis HD ultra-high resolution (UHR) Q-TOF mass spectrometer equipped with a Apollo II electrospray source (Bruker Daltoniks, Bremen, Germany) and an Ultimate 3000RS autosampler together with a binary high gradient pump (Dionex/Thermo Fisher Scientific, Waltham, MA, United States). A solvent flow of 50 μL/min was used for infusion of a calibrating solution as well as for the sample. Data were processed using the Data Analysis Software Version 4.2 (Bruker Daltoniks). Original mass spectra containing peaks from multiply charged ions were smoothed and deconvoluted to obtain a singly charged mass spectrum. The UV traces of the size exclusion polishing step, SDS PAGE analysis of purified proteins and ESI-MS spectra are shown in Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}.

Small Angle X-Ray Scattering (SAXS) Analysis
--------------------------------------------

The oligomeric states of the purified proteins were assessed by SAXS experiments at beamline BM29 at the European Synchrotron Radiation Facility (ESRF, Grenoble, France; [@B74]) equipped with a PILATUS 1M detector and by using a sample detector distance of 2.867 m and a wavelength of λ = 0.9919. All data collection steps were carried out at 4°C and scattering data from buffer ingredients were subtracted from protein scattering data using PRIMUS software ([@B50]). Best data were obtained in 20 mM HEPES pH 7.5, 100 mM NaCl, 3 mM DTT and with 0.63 and 1.25 mg/mL of sheath protein CD1363 or tube protein CD1364, respectively. Scattering data were normalized, averaged and merged using PRIMUS software and SAXS envelopes were calculated with DAMMIF, DAMSEL, DAMSUP, DAMAVER, and DAMFILT of the ATSAS software package ([@B23]). Fitting of the respective crystal structures with the experimental scattering curves and with the calculated envelopes was performed with CRYSOL ([@B93]) or with UCSF Chimera ([@B75]), respectively.

Protein X-Ray Crystallography and Structure Determination
---------------------------------------------------------

Vapor diffusion experiments were set up in a 96-well sitting drop format at 19°C using a dispensing robot (Zinsser Analytics, Frankfurt, Germany). 0.1 μL protein solution at a concentration of 20 mg/mL for both the SeMet-labeled sheath protein CD1363 and native tube protein CD1364 were mixed with an equal amount of reservoir to give concentrations listed in **Table [1](#T1){ref-type="table"}**. The drops were equilibrated against 70 μL of reservoir solution and crystals appeared after a few days. Before flash cooling the crystals in liquid nitrogen, 10% (v/v) of (*2R,3R*)-(-)-2,3-butanediol was added as cryoprotectant.

###### 

Crystallization, data collection and refinement statistics, ^1^values in parenthesis correspond to highest resolution shell.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                            SeMet-labeled CD1363 (PDB: 6GKW)                                                                           Native CD1364 (PDB: 6GKX)
  ----------------------------------------- ---------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  **Crystallization and data collection**                                                                                                              

  Crystallization buffer                    0.1 M Bis-Tris pH 5.5, 25% (w/v) PEG 3350                                                                  20% (w/v) PEG 3350, 0.2 M ammonium chloride

  Crystallization drop                      0.1 μL crystallization buffer + 0.1 μL of 20 mg/mL protein in 20 mM HEPES, 300 mM NaCl, 3 mM DTT, pH 7.5   0.1 μL crystallization buffer + 0.1 μL of 20 mg/mL protein in 20 mM HEPES, 300 mM NaCl, 3 mM DTT, pH 7.5

  Wavelength (Å)/beamline                   0.97945/SLS PXII                                                                                           0.918/BESSY II 14.1

  Resolution range (Å)                      40.49--1.90 (1.94--1.90)                                                                                   43.36--1.50 (1.53--1.50)

  Space group                               C121                                                                                                       P4~3~2~1~2

  Unit cell parameters\                     \                                                                                                          \
      a, b, c (Å)\                          75.9, 47.9, 112.5\                                                                                         36.3, 36.3, 216.8\
      α, β, γ (°)                           90.0, 92.3, 90.0                                                                                           90.0, 90.0, 90.0

  Mosaicity (°)                             0.22                                                                                                       0.10

  Total no. of measured reflections         432621 (27802)                                                                                             613640 (30875)

  Unique reflections                        32088 (2087)                                                                                               24715 (1195)

  Multiplicity                              13.5 (13.3)                                                                                                24.8 (25.9)

  Mean I/σ(I)                               21.5 (1.8)                                                                                                 19.7 (1.7)

  Completeness (%)                          99.9 (99.8)                                                                                                100.0 (100.0)

  R*~meas~* (%)                             8.8 (156.6)                                                                                                8.5 (233.5)

  R*~p.i.m.~* (%)                           2.4 (42.1)                                                                                                 1.7 (45.5)

  CC1/2 (%)                                 100.0 (72.6)                                                                                               100.0 (70.4)

  Wilson B-factor (Å^2^)                    32.20                                                                                                      20.97

  Monomers/asymmetric unit                  1                                                                                                          1

  **Refinement**                                                                                                                                       

  Resolution range (Å)                      38.36--1.90 (1.96--1.90)                                                                                   35.83--1.50 (1.57--1.50)

      R~work~ (%)                           21.31 (31.66)                                                                                              19.15 (26.78)

      R~free~ (%)                           24.85 (36.22)                                                                                              22.00 (30.95)

  No. of non-H atoms                                                                                                                                   

      Protein                               2705                                                                                                       1075

      Water                                 180                                                                                                        129

  RMS deviation                                                                                                                                        

      Bonds (Å)                             0.003                                                                                                      0.010

      Angles (°)                            0.518                                                                                                      1.043

  Average B factors (Å^2^)                                                                                                                             

      Protein                               51.58                                                                                                      37.07

      Water                                 45.56                                                                                                      38.29

      All atoms                             51.21                                                                                                      37.20

  Ramachandran plot                                                                                                                                    

      Favored regions (%)                   97.4                                                                                                       97.7

      Allowed regions (%)                   2.6                                                                                                        2.3

      Outliers (%)                          0.0                                                                                                        0.0
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

X-ray data collection for native tube protein CD1364 was carried out at 100 K at beamline 14.1 at BESSY II (Helmholtz-Zentrum Berlin (HZB), Berlin, Germany; [@B30]). For SeMet-labeled sheath protein CD1363, a SAD data set was collected on beamline PXII at the Swiss Light Source (SLS; Paul Scherrer Institut, Villigen, Switzerland; [@B24]). Diffraction data were indexed, integrated and scaled with XDS ([@B43]) and AIMLESS ([@B22]) from the CCP4 suite ([@B109]). Details of data collection are listed in **Table [1](#T1){ref-type="table"}**. The structure of SeMet-labeled sheath protein CD1363 was determined using AUTOSOL ([@B99]). Eight SeMet sites were identified, indicating the presence of one molecule in the asymmetric unit ([@B64]; [@B109]). The structure of the native tube protein CD1364 was solved by molecular replacement with PHASER ([@B65]), using a truncated model of a monomer of P54332 from *Bacillus subtilis* (*B. subtilis*; PDB: 2GUJ; unpublished). Initial model building was performed using AUTOBUILD ([@B100]) and final models were obtained by iterative cycles of TLS-motion refinement with PHENIX.REFINE ([@B3]) and manual rebuilding using COOT ([@B21]). All programs were run through the PHENIX suite ([@B2]). Coordinates of the SeMet-labeled sheath protein CD1363 and tube protein CD1364 structures are available at the PDB^[2](#fn02){ref-type="fn"}^ ([@B10]) under accession codes 6GKW and 6GKX and refinement statistics are summarized in **Table [1](#T1){ref-type="table"}**. Secondary structure elements were assigned using the DSSP web server ([@B44]; [@B102]). The DALI web server ^[3](#fn03){ref-type="fn"}^ was used to analyze structural similarities and to calculate Z-scores as well as sequence similarities toward homologous proteins ([@B39]). Sequence alignments were generated with the PROMALS3D web server ^[4](#fn04){ref-type="fn"}^ ([@B73]) and alignment figures were prepared with the ESPript 3.0 web server ^[5](#fn05){ref-type="fn"}^ ([@B78]) after manual editing. Structural figures were prepared using PyMOL (The PyMOL Molecular Graphics System Version 1.8.2.3; [@B87]) including the APBS plugin for electrostatic potential surface presentations ([@B6]). Topology diagrams were generated using TopDraw ([@B13]).

Structure Modeling of the Sheath and Tube Assemblies in Extended R-Type Diffocin
--------------------------------------------------------------------------------

Structural alignments were generated by superimposing the sheath and tube proteins CD1363 and CD1364 on monomers of the R-type pyocin sheath protein FIR2 (PDB: 3J9Q; [@B26]) or the bacteriophage φ812 tail tube protein gp104 (PDB: 5LI2; [@B72]) via the DALI web server ([@B39]). Using PyMOL (The PyMOL Molecular Graphics System Version 1.8.2.3; [@B87]) as well as the protein comparison tool from the RCSB PDB^[6](#fn06){ref-type="fn"}^, the obtained alignments were visually inspected and manually adjusted. Models of tube and sheath assembles were generated on the basis of the R-type pyocin sheath (PDB: 3J9Q; [@B26]) and the bacteriophage φ812 tail tube (PDB: 5LI2; [@B72]) using MODELLER ([@B107]). The models were further treated by two cycles of VTFM-based optimization and MD-based refinement in slow mode ([@B79]) as implemented in MODELLER ([@B107]). Loops and secondary structure elements that exhibited severe clashes such as residues F36--G55, Y65--S68, and V121--G125 of the tube protein CD1364 and residues Y308--E326 of the sheath protein CD1363 were excluded from the assembly. Since the 5LI2 template used for modeling of the tube disk comprises a single layer only, generation of two additional disks was achieved via superimposition of both single disks of R-type diffocin sheath and tube onto 5LI2 and their subsequent merging. Afterward, the merged model contained both an R-type diffocin sheath and tube and was superimposed back onto two adjacent R-type diffocin disks of the pyocin-based sheath model such that the three-layered tube structure follows the sheath geometry of this model. Figures were generated as described above.

Results and Discussion
======================

Cloning, Expression, and Purification
-------------------------------------

Genes of CD1363 and CD1364 from *C. difficile* strain 630 were successfully PCR-amplified from genomic DNA and subcloned into a pOPINM expression vector ([@B11]) via SLIC ([@B61]), using the oligonucleotide primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. Positive clones for both constructs were identified via colony PCR and the correct sequences were confirmed via sequencing.

During test expression experiments, the highest yields of soluble protein were obtained with *E. coli* BL21-CodonPlus-RIL cells in auto-induction medium ([@B92]) for both proteins. However, since SeMet-labeling was required to determine the structure of sheath protein CD1363, large-scale expression for this protein was performed in M9 minimal medium ([@B69]).

The obtained fusion proteins comprised a combination of an N-terminal 6xHis and an MBP-tag followed by a HRV3C protease cleavage site to remove both tags simultaneously. The proteins were affinity-purified using an MBPTrap HP column (GE Healthcare Life Sciences, Pittsburgh, PA, United States). Subsequently, the N-terminal 6xHis-MBP-tags were cleaved off with HRV3C protease during overnight incubation and uncleaved fusion protein along with free N-terminal tags were removed using a 5 mL HisTrap^TM^ HP column (GE Healthcare Life Sciences). Tag-free CD1363 (˜39 kDa) and CD1364 (˜16 kDa) were identified in the flow-through, concentrated and then finally purified via gel filtration, in which both proteins eluted as single prominent peaks (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). Via mass spectrometry analysis using electrospray ionization (ESI)-TOF, the full integrity and correct molecular weight were confirmed for the pooled fractions (CD1363: theoretical mass: 39344.5547 Da, experimental mass: 39345.3228 Da; CD1364: theoretical mass: 16161.4824 Da, experimental mass: 16161.8672 Da; Supplementary Figure [S1B](#SM1){ref-type="supplementary-material"}).

General Organization of the R-Type Diffocin Tube Protein CD1364
---------------------------------------------------------------

The R-type diffocin tube protein CD1364 crystallized in space group P4~3~2~1~2 containing one molecule in the asymmetric unit. Initial phases were obtained by molecular replacement using a truncated model of a single central β-barrel from the phage-like element P54332 protein XkdM from *B. subtilis* (PDB: 2GUJ, unpublished), and the structural model was subsequently refined to a resolution of 1.5 Å with R~work~ = 19.15% and R~free~ = 22.00% (**Table [1](#T1){ref-type="table"}**).

CD1364 possesses a compact fold with a central β-barrel flanked by two α-helices at both of its open sides (**Figures [2A,B](#F2){ref-type="fig"}**). Whereas α-helices α2 and α4 cap the β-barrel on one side, the α-helices at the other protrude away from the β-barrel such that α1 covers the β-barrel of a symmetry-related neighbor (**Figure [2A](#F2){ref-type="fig"}**). Higher B-factors indicate increased flexibility for α1, which hints at structural changes that may occur during tube assembly.

![Structural analysis of *Clostridium difficile* R-type diffocin tube protein CD1364. The structures of monomeric CD1364 (blue and red) and a symmetry-related molecule (gray) are shown as cartoon representation in **(A)** and the corresponding topology diagram is shown in **(B)**. Secondary structure motifs are numbered consecutively. SAXS analysis of purified CD1364 is presented in **(C)** with a fit of the experimental SAXS data (black dots) and a theoretical curve calculated from the crystal structure (green dots) together with the CD1364 crystal structure fitted to the calculated SAXS envelope. In **(D)**, monomeric structures from homologous tube assembles of R-type pyocin (FIIR2; PDB: 5W5E; [@B111]) and the bacteriophage φ812 tail (gp104; PDB: 5LI2; [@B72]) were superimposed onto CD1364. N- and C-termini are labeled with N and C, respectively.](fmicb-09-01750-g002){#F2}

As was suspected from the molecular replacement process, CD1364 shares highest structural and sequence similarity with XkdM from *B. subtilis* as well as with gp104 from the bacteriophage φ812 tail tube ([@B72]) (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}), and the overall fold for these proteins is mainly preserved (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Conserved residues are primarily identified within β1, β2, β3, and β6 as well as in α1 and α2 (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}). Notably, in XkdM, α1 does not protrude away from the core of the structure such as in the crystal structure of CD1364 discussed here, but rather caps the β-barrel of the same molecule, again suggesting a high degree of flexibility for this region in both CD1364 and XkdM (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}).

Although the corresponding sequence identity is low, tube structures of other bacteriophage tails, bacterial T6SSs and R-type pyocin can be superimposed with reasonable rmsd onto CD1364 (**Figure [2D](#F2){ref-type="fig"}** and Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). These structures all have a central β-sheet architecture with at least one α-helix (α2 in CD1364) in common ([@B15]). However, the β-sheet does not appear as compact as in CD1364 and can rather be described as two β-sheets tilted by an angle of 90° ([@B26]) among the less related homologs such as FIIR2 from R-type pyocin (PDB: 3J9Q, 5W5E; [@B26]; [@B111]), the T6SS hemolysin co-regulated tube protein 1 (HCP1) from *Burkholderia pseudomallei* (PDB: 3WX6; [@B62]) or phage tail tube protein gp19 from bacteriophage T4 (PDB: 5W5F; [@B111]; Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). In addition, several differing loop conformations as well as insertions of secondary structure elements are observed. Particularly, a prominent loop (K33--G58 in CD1364) is variable and folds into a flexible α-helix in CD1364 (α1), XkdM from *B. subtilis* and HCP1 from the T6SS of *B. pseudomallei* ([@B62]), whereas these residues form a protruding β-hairpin in FIIR2 as well as in gp19 from bacteriophage T4 ([@B111]; **Figure [2D](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Interestingly, the number of amino acids of this loop is nearly unchanged (25--28) and although several residues from this region contribute to inter-disk contacts in the assembled tubes of bacterial T6SSs, the tail of bacteriophage T4 as well as R-type pyocin ([@B26]; [@B62]; [@B106]; [@B111]), the corresponding sequence is not conserved ([@B62]), indicating potentially different principles of tube assembly in these particles.

General Organization of the R-Type Diffocin Sheath Protein CD1363
-----------------------------------------------------------------

The R-type diffocin sheath protein CD1363 crystallized in space group C121 with one molecule in the asymmetric unit. Despite extensive attempts, it was not possible to determine the structure via molecular replacement. Therefore, SAD data were collected from a crystal obtained from SeMet-labeled CD1363 protein. These crystals were of the same space group and exhibited identical cell parameters, allowing for straightforward structure solution and refinement. Because crystals of the labeled protein diffracted to higher resolution, the structure was refined against these data (**Table [1](#T1){ref-type="table"}**) and the subsequent discussion refers to SeMet-labeled CD1363.

In the crystal form discussed here, CD1363 is monomeric and comprises two domains (**Figure [3A](#F3){ref-type="fig"}**). The domain arrangement is best described as a "Russian doll" system ([@B5], [@B4]) in which domain II (residues G26--S225; domain numbering according to [@B59]) is an insertion into domain I (residues G4--R25 and residues L226--I354; **Figure [3B](#F3){ref-type="fig"}** and Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}). At the N-terminus, residues P6--A25 form a long α-helix that closely interacts with α-helices α9 and α10, which flank the central antiparallel three-stranded β-sheet. Domain I is furthermore completed by three smaller α-helices. The larger domain II is composed of a central six-stranded β-sheet and five smaller β-strands flanked by four and two α-helices, respectively (**Figure [3A](#F3){ref-type="fig"}**).

![Structural analysis of *Clostridium difficile* R-type diffocin sheath protein CD1363. The structure of monomeric CD1363 is shown as cartoon representation in **(A)** with Domain I and II colored in yellow and orange, respectively. Domain I contains a central three-helix bundle that is stabilized by hydrophobic interactions and by a salt bridge (see insert). The C-terminal part of this domain is organized as a three-stranded β-sheet that hydrophobically interacts with the helix bundle. The general domain organization of CD1363 is shown as topology diagram in **(B)**. SAXS analysis of purified CD1363 is presented in **(C)** with a fit of the experimental SAXS data (black dots) and a theoretical curve calculated from the crystal structure (orange dots) as well as a fit of the CD1364 crystal structure to the SAXS envelope. In **(D)**, monomeric structures of homologous sheath proteins from assembled R-type pyocin (FIIR2; PDB: 3J9R; [@B26]) and from monomeric DSY3957 from *Desulfitobacterium hafniense* (PDB: 3HXL; [@B4]) were superimposed onto CD1363. N- and C-termini are labeled with N and C, respectively.](fmicb-09-01750-g003){#F3}

Despite relatively low sequence identities, several PDB entries related to sheath protein CD1363 were identified via the DALI web server ([@B39]), and the corresponding rmsd as well as Z-scores indicate a conserved fold for domain I and II of CD1363 (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}). However, apart from the R-type pyocin sheath protein FIR2 ([@B26]), all related structures contain one or two additional domains (domain III and IV) likewise organized as insertions of one another in a Russian doll arrangement. Generally, the architecture of sheath domain III and IV is less conserved and differs between the contractile systems (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}). For instance, the fold of the surface-exposed domain III of T6SSs is highly T6SS-specific and plays a crucial role for the recycling mechanism of the contracted sheath in these systems ([@B59]; [@B91]; [@B53]; [@B15]; [@B106]).

Yet, sheath proteins containing only domains I and II still form complete sheath assemblies as has been demonstrated for FIR2 or CD1363 of the R-type pyocins and diffocins, respectively ([@B85]; [@B28]; [@B26]). This indicates that the R-type bacteriocin sheath proteins represent the minimal requirement for sheath formation ([@B97]), which is in contrast to former studies suggesting that at least three domains are necessary ([@B4] with differing domain annotation).

Oligomeric State of the Sheath and Tube Proteins CD1363 and CD1364
------------------------------------------------------------------

The ability of the sheath and tube subunits to assemble into oligomeric structures is essential for the formation of fully functional bacteriophage tails, T6SSs or R-type PTLBs. Typically, polymerization of the tube as well as of the uncontracted sheath is initiated upon binding to initiation factors in the baseplate, and assembly of the sheath furthermore requires the tube polymer as a template ([@B51]; [@B59]; [@B53]). However, despite these external factors, preparations of purified tube and sheath proteins have been observed to also spontaneously self-assemble into oligomers *in vitro*. For instance, tube proteins of bacterial T6SSs pack into hexameric rings in the absence of baseplate components ([@B7]; [@B58]; [@B19]), whereas tail sheath proteins of bacteriophage T4 as well as φKZ assemble into irreversibly contracted polysheaths of different lengths without the tube structure or the baseplate components being present ([@B70]; [@B20]; [@B54]). This can impede crystallization and structure determination, especially when assessing the unassembled state of these proteins.

In contrast to homologous proteins from other sources, recombinant purified R-type diffocin tube and sheath proteins CD1364 and CD1363 showed no tendency for spontaneous assembly but eluted predominantly in single prominent peaks at volumes corresponding to the molecular weight of the monomeric species in size exclusion chromatography (CD1364: 16 kDa; CD1363: 39 kDa; Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). To further compare their oligomeric states in solution with the crystal structures described above, SAXS experiments have been performed here. As indicated by low χ-values of 0.71 for CD1364 and 1.84 for CD1363, the theoretical curves calculated from the crystal structures fitted well with the experimental SAXS data as well as with the calculated envelopes, confirming their monomeric state in solution (**Figures [2C](#F2){ref-type="fig"}, [3C](#F3){ref-type="fig"}**). Notably, in the tube protein CD1364, α1, which interacts with a neighboring molecule in the crystal structure, sticks out of the calculated envelope. This suggests that the interaction observed in the crystal structure is a consequence of crystallization and that α1 is not swapped in solution but rather packs onto the β-barrel of the same molecule such as observed for tube protein XkdM from *B. subtilis* (PDB: 2GUJ; unpublished; Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Thus, based on our results, we can conclude that the sheath and tube proteins CD1363 and CD1364 adopt a stable monomeric pre-assembly state after translation and that this state is reflected in the crystal structures obtained here. However, as will be outlined in the following paragraph, significant structural changes are likely to accompany formation of the fully assembled R-type PTLB particle.

Comparison to Homologs Proteins in the Free and Particle-Assembled State
------------------------------------------------------------------------

As stated above, both the sheath and the tube proteins assemble to sixfold symmetrical disks that stack on top of each other with a slight right-handed rotation in PTLBs ([@B38]; [@B26]; [@B72]; [@B80]). Comparison of the crystal structures of the monomeric tube and sheath proteins CD1364 and CD1363 to homologous proteins in these assemblies allows for speculation about structural changes that may accompany particle formation.

CD1364 can be superimposed with low rmsd values onto the hexameric assembly of tube protein gp104 in an electron microscopy structure of the native bacteriophage *φ812* tail (PDB: 5LI2; [@B72]) (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). Comparison reveals that the architecture of the central β-barrel mainly remains unaltered in the assembled tube whereas positions of α-helices α2, α3, and α4 are significantly changed. In the hexameric assembly, α4 establishes interactions with neighboring subunits of the same disk and of one disk below, whereas α2 tightly packs onto the β-barrel of the same molecule (**Figure [2D](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). Both α-helices are located at the outer surface of the tube. Comparison with the monomeric structure of XkdM from *B. subtilis* (PDB: 2GUJ) suggests that the movement of α2 can be described as a rotation such that residues that point toward α4 in the unassembled structure face the β-barrel in the hexameric ring. Furthermore, α3 of CD1364 forms into an extended loop in gp104 and interacts with α2 of the adjacent molecule on the other site of the β-barrel. With respect to the mobile α1, no conclusions can be drawn on basis of the *φ812* tail tube structure, as the corresponding loop region is not resolved in PDB entry 5LI2. However, given the fact that the number of residues in the loop comprising α1 is almost identical even among less homologous proteins, further conclusions may be drawn from tube structures of other contractile systems, such as that of FIIR2 from R-type pyocin (PDB: 3j9Q, 5W5E; [@B26]; [@B111]) or gp19 from the bacteriophage T4 tail (PDB: 5W5F; [@B111]). As has been outlined above, the corresponding loop folds into a protruding β-hairpin in these assemblies (**Figure [2D](#F2){ref-type="fig"}** and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). This β-hairpin runs underneath an adjacent molecule of the same disk and thus connects it to two molecules of the lower disk in these tube assemblies. Similarly, the smaller loop region that corresponds to α4 in CD1364 forms into β-strands that extend the central β-barrel in both FIIR2 and gp19 and mainly interact with the central β-sheet of the adjacent subunit (**Figure [4A](#F4){ref-type="fig"}**). These conformational arrangements generate a continuous antiparallel β-sheet of 24 β-strands that spans the complete inner surface of the tube structure ([@B26]; [@B17]; [@B106]; [@B111]). Together, this indicates that assembly of the R-type diffocin tube structure not only requires movements of the four α-helices such as observed for the *φ812* tail tube but might also involve significant refolding, specifically around α1.

![Structural differences between monomeric R-type diffocin sheath and tube proteins CD1364 and CD1363 and the respective subunits in the R-type pyocin particle. Two subunits (FIIR2) from two disks of the tube (PDB: 5W5E; [@B111]) are shown (blue and yellow) in cartoon presentation for pyocin in **(A)**. A β-hairpin runs underneath a neighboring molecule of the same disk and establishes interactions with the molecules of one disk below. Each β-barrel is extended by two β-strands that form interactions with the adjacent central β-barrel. In **(B)**, three subunits (FIR2) from two disks of the R-type pyocin sheath assembly (PDB: 3J9Q; [@B26]) forming a four-stranded β-sheet via exchanging and refolding of the N- and C-termini are shown (labeled with N and C, respectively). For comparison, structures of the monomeric unassembled R-type diffocin tube CD1364 and sheath CD1363 proteins are presented and regions that correspond to the respective R-type pyocin elements are indicated by red coloring.](fmicb-09-01750-g004){#F4}

In the sheath protein, significant refolding upon particle assembly seems to occur within the N- and C-termini especially, as can be concluded by an overlay of monomeric CD1363 with the electron microscopy structure of FIR2 in the assembled R-type pyocin from *P. aeruginosa* (PDB: 3J9Q, 3J9R; [@B26]). While the N-terminus of monomeric CD1363 folds into a long α-helix (α1; P6--A24) that packs tightly against two other long α-helices of domain I (α9 and α10) via extensive hydrophobic interactions (**Figure [3A](#F3){ref-type="fig"}** magnified insert, **Figure [3B](#F3){ref-type="fig"}**, and Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}), it adopts an extended structure in FIR2 of the *P. aeruginosa* R-type pyocin particle (**Figure [3D](#F3){ref-type="fig"}** and Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}) to contribute a new strand to a β-sheet with three parallel and one antiparallel strand in the C-terminal region of domain I within a monomer of the next disk. This β-sheet is further expanded by a strand from the C-terminus of the monomer neighboring the chain that contributes the N-terminus from the disk below (**Figure [4B](#F4){ref-type="fig"}**). This creates an "interwoven mesh" that connects not only the monomers within one disk but also ties neighbored disks to one another both in the extended and contracted state ([@B26]). Similar mesh-like organizations have been found in several T6SSs, indicating that these interactions are likewise conserved in assembled R-type PTLBs ([@B18]; [@B53]; [@B80]). Interestingly, the C-terminus in monomeric CD1363 also forms a β-strand (β14) that hydrophobically interacts with residues of α9 and α10 as well as with the same residues from the neighboring β-strand (β13 in CD1363) as observed in the pyocin particle, albeit within the same chain (**Figure [3A](#F3){ref-type="fig"}** magnified insert and **Figure [3B](#F3){ref-type="fig"}**). This indicates that the length of the C-terminus is perfectly evolved to enable sheath formation by arm exchange between chains lying next to each other. At the same time, the hydrophobic character of residues in the refolded N-terminus is conserved (Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}), and the finding that the N-terminus adopts a similar α-helix in the prophage sheath protein LIN1278 from *Listeria innocua* (PDB: 3LML; [@B4]) suggests that the formation of the contractile apparatus of R-type PTLBs is enabled by low refolding barriers of the N- and C-terminal sequences in domain I of the sheath proteins. This is also corroborated by the crystal structure of the prophage sheath protein DSY3957 from *Desulfitobacterium hafniense* (PDB: 3HXL; [@B4]), where the N-terminus displays similar structure and interactions as in the assembled FIR2 sheath structure (**Figure [3D](#F3){ref-type="fig"}**), even if the crystal structure does not reveal disks as in the PTLBs. Notably, sheath formation involves only residues from domain I, whereas domain II is positioned at the surface of the sheath where it does not contact other subunits or the tube (**Figure [4B](#F4){ref-type="fig"}**), which is also expected for domain III and IV in sheath proteins gp18, LIN1278, and DSY3957 (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"} and Supplementary Table [S3](#SM1){ref-type="supplementary-material"}).

In bacterial T6SSs as well as bacteriophage tails, baseplate gp48/54/gpU and gp25 subunits are required to initiate tube and sheath polymerization, respectively ([@B71]; [@B51]; [@B59]; [@B16]), and similar proteins are found in the gene clusters of Afp, PVC, or R-type pyocin ([@B81]; [@B52]). Using fold recognition via the Phyre2 ^[7](#fn07){ref-type="fn"}^ web server ([@B47]), the ORF CD1370 of *C. difficile* strain 630 was found to encode a protein with high homology to the sheath initiator protein gp25 of T4 bacteriophage (PDB: 5IW9; [@B28]; [@B96]), but no tube initiator could be identified via this approach. In the recent structure of the baseplate of T6SS from T4 bacteriophage (PDB: 5IV5, 5IV7), gp25 adopts the same sixfold symmetry as observed in the assembled sheath of R-type pyocins and sheath polymerization initiation likely involves a similar β-strand exchange mechanism as described above ([@B96], [@B97]). Thus, conformational changes for the first layer of pre-assembled sheath proteins are probably induced upon binding to a homologous sheath initiator protein that might be present in every baseplate complex ([@B15]).

Preliminary Model of the Contractile Apparatus of R-Type Diffocin in the Extended State
---------------------------------------------------------------------------------------

Based on the high homology of CD1364 to the assembled tube protein in the tail of bacteriophage *φ812* (PDB: 5LI2; [@B72]) as well as of CD1363 to FIR2 in the assembled sheath of the extended R-type pyocin structure (PDB: 3J9Q; [@B26]), we constructed a preliminary model of the extended R-type diffocin particle using MODELLER ([@B107]). As common for phage tail-like contractile systems, the sheath and tube disks of the used templates are organized with identical helical symmetry ([@B26]; [@B96], [@B97]; [@B106]), and the resulting model of R-type diffocin re-iterates the observed pitch of disks in R-type pyocin (translation of approximately 38 Å, rotation of 18°; [@B26]; **Figure [5A](#F5){ref-type="fig"}**) However, since several residues were not resolved in the tube template (PDB: 5LI2), the corresponding loops including the potentially important region around α1 could not be modeled, causing substantial gaps between the tube disks (**Figure [5C](#F5){ref-type="fig"}**). In the R-type pyocin tube, these gaps are primarily occupied by the protruding β-hairpin discussed earlier, which underlines the potential importance of structural rearrangements in R-type diffocin building blocks. In the sheath assembly, in contrast, only a few residues had to be excluded and the model reflects the extensive mesh-like interactions as well as the prominent surface ridges known from other contractile systems in the extended sheath very well (**Figure [5B](#F5){ref-type="fig"}**) ([@B18]; [@B26]; [@B53]; [@B106]; [@B80]).

![Preliminary model of the extended sheath and tube assembly of R-type diffocin, generated on the basis of the sheath from R-type pyocin (PDB: 3J9Q; [@B26]) and the tube of phage φ812 tail (PDB: 5LI2, [@B72]). A top view onto three disks of CD1363 sheath and CD1364 tube layers is given in **(A)** with the interacting subunits colored in yellow, red, and green, respectively. In **(B)**, a side view of three disks of the CD1363 sheath assembly is shown. Because of helical disk stacking, the surface ridges wind around the particle. In **(C)**, three disks of tube subunits are presented using the same color code as in **(A,B)**. Of note, since the 5LI2 template for tube modeling contained a single tube disk only, generation of two additional disks for the R-type diffocin tube was performed via superimpositions on pyocin as described in the "Materials and Methods" section. White stars indicate positions of the attachment points for the loop comprising α-helix 1 in CD1364, which was excluded from the model due to clashes but might establish important inter-disk contacts to fill the gaps observed in the tube assembly. In **(D)**, putative contact points between sheath and tube subunits of the R-type diffocin particle with the respective electrostatic potential are shown. For CD1363, the attachment helix α10 and for CD1364, the central β-barrel, is shown as cartoon.](fmicb-09-01750-g005){#F5}

In the R-type pyocin, the main contacts between sheath and tube are established via electrostatic interactions of a positively charged region in attachment helix α10 of sheath domain I with a complementarily charged patch in the central β-barrel of the respective tube protein ([@B26]). We examined the electrostatic potential of the modeled R-type diffocin sheath and tube for similarly charged patches and our analysis indeed revealed equivalent regions in the sheath and tube but with opposite charges (**Figure [5D](#F5){ref-type="fig"}**). Indeed, the sequence alignment of homologous sheath proteins demonstrates that the positions of basic residues in α10 are not conserved among these proteins (Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}). However, our finding of opposite charges with respect to R-type pyocin may be a consequence of our preliminary model not accurately reflecting all aspects of the diffocin particle, which is also underpinned by clashes seen between attachment helix α10 and tube residues. This reiterates once more that further rearrangements seem to be required for R-type diffocin particle formation (**Figure [5A](#F5){ref-type="fig"}**). The revelation of detailed interactions will thus have to await cryo-EM studies, for which promising preliminary work has recently been published ([@B37]).

Conclusion
==========

Here, we have determined the crystal structures and SAXS envelopes of the R-type diffocin tube and sheath protein CD1364 and CD1363 in their pre-assembled monomeric state. Our data indicate that several conformational changes are necessary to enable formation of the diffocin particle, which, together with the finding that recombinant monomers of both proteins were stable enough for crystallization studies, indicates that the refolding energy barriers in diffocins are higher than in similar assemblies with spontaneously self-assembling building blocks. This could make the R-type diffocins an ideal system to study the particle formation process *in vitro*. Further, the crystal structures of CD1364 and CD1363 together with cryo-EM structures of related particles enabled us to construct a preliminary model of the contractile apparatus of R-type diffocins, but because significant differences to the available templates exist, several structural details will have to be revealed in future studies addressing the complete diffocin particle.
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